Verrica Pharmaceuticals Inc. (VRCA)
Symbol Info
Listed Symbol VRCA
Name Verrica Pharmaceuticals Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $-
Latest Fiscal EPS $-1.95
Price Info
21 Day Moving Average $10.4467
21 Day EMA $10.161480
50 Day Moving Average $10.2218
50 Day EMA $10.203390
200 Day EMA $11.243630
200 Day Moving Average 10.700080
52 Week High $18.58
52 Week Low $6.44
52 Week Change $-42.919300
Alpha -0.047236
Beta 4.0791
Standard Deviation 0.267786
R2 0.615624
Periods 14
Share Information
10 Day Average Volume 26,656
20 Day Average Volume 29,843
30 Day Average Volume 35,398
50 Day Average Volume 53,343
Outstanding Shares 25,741,297
Float Shares 14,653,943
Percent Float 56.93%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 95
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months 697,025
Institute Holdings Percent 41.800000
Institute Sold Previous 3 Months 116,565
Insider Holdings Date 2019-07-31
Insider Bought Previous 3 Months 4
Insider Holdings Percent 43.10%
Insider Sold Previous 3 Months 16,830
Insiders Shares Owned 11,087,354
Price Change
7 Day Price Change $-0.6400003
7 Day Percent Change -6.51%
21 Day Price Change $-1.7200003
21 Day Percent Change -15.77%
30 Day Price Change $-1.7000008
30 Day Percent Change -15.61%
Month To Date Price Change $-3.05
Month To Date Percent -24.92%
90 Day Price Change $0.070000
90 Day Percent Change 0.77%
Quarter To Date $-2.43
Quarter To Date Percent -20.91%
180 Day Price Change $-3.520001
180 Day Percent Change -27.69%
200 Day Price Change $-1.92
200 Day Percent Change -17.28%
Year To Date $1.040000
Year To Date Percent 12.76%
Profile
Description Verrica Pharmaceuticals Inc a clinical-stage biopharmaceutical company. The company is primarily focused on identifying, developing and commercializing pharmaceutical products for the treatment of skin diseases with unmet needs. Its pipeline product includes NCT03377803, and NCT03377790.
Details
Issue Type CS
Market Cap $236,562,519
Sec Type
Auditor KPMG LLP
Total Shares Outstanding 25,741,297
CEO Ted White
Employees 16
Last Audit UE
Classification
CIK 0001660334
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 10 North High Street
Suite 200
West Chester, PA 19380
Website https://www.verrica.com
Facisimile
Telephone +1 484 453-3300
Email info@verrica.com
Key Ratios
Profitability
EBIT Margin -
EBITDA Margin -
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $-
Revenue Per Share $-
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $146,987,761
Price To Sales -
Price To Free Cash -9.1
PE High Last 5 Years -
Price To Book 2.9
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 2.9
Financial Strength
Total Debt To Equity -
Int Coverage -
Current Ratio 18.6
Leverage Ratio 1.0
Quick Ratio 18.4
Long Term Debt To Capital -
Assets
Receivables Turnover -
Invoice Turnover -
Assets Turnover -
Management Effectiveness
Return Assets -30.07
Return On Equity -31.34
Return On Capital -33.61
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type
Your Recent History
NASDAQ
VRCA
Verrica Pa..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20190818 13:31:02